1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione

C78H90N10O11 — CID 159474340

IUPAC1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione
SMILESCOc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CC(=O)N2CCOCC2)cc1.Cc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CC(=O)N2CCOCC2)cc1.Cc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CN2CCN(C)CC2)cc1
InChIInChI=1S/C26H32N4O2.C26H29N3O5.C26H29N3O4/c1-18-3-6-21(7-4-18)26-22-10-9-20-8-5-19(17-31)15-23(20)25(22)27-30(26)24(32)16-29-13-11-28(2)12-14-29;1-33-20-7-4-19(5-8-20)26-21-9-6-18-3-2-17(16-30)14-22(18)25(21)27-29(26)24(32)15-23(31)28-10-12-34-13-11-28;1-17-2-5-20(6-3-17)26-21-9-8-19-7-4-18(16-30)14-22(19)25(21)27-29(26)24(32)15-23(31)28-10-12-33-13-11-28/h3-8,15,22,26,31H,9-14,16-17H2,1-2H3;2-5,7-8,14,21,26,30H,6,9-13,15-16H2,1H3;2-7,14,21,26,30H,8-13,15-16H2,1H3/t22-,26-;2*21-,26-/m111/s1
InChIKeyLWEOBWUAGHVZKI-UBJSVJMQSA-N
MW1343.64 g/mol
LogP7.46
Rot. Bonds13

About 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione

1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione (PubChem CID 159474340) has the molecular formula C78H90N10O11 and a molecular weight of 1343.64 g/mol. Its IUPAC name is 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione.

Molecular Properties

Compound Name1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione
PubChem CID159474340
Molecular FormulaC78H90N10O11
Molecular Weight1343.64 g/mol
Exact Mass1342.68
IUPAC Name1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione
SMILESCOc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CC(=O)N2CCOCC2)cc1.Cc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CC(=O)N2CCOCC2)cc1.Cc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CN2CCN(C)CC2)cc1
InChIInChI=1S/C26H32N4O2.C26H29N3O5.C26H29N3O4/c1-18-3-6-21(7-4-18)26-22-10-9-20-8-5-19(17-31)15-23(20)25(22)27-30(26)24(32)16-29-13-11-28(2)12-14-29;1-33-20-7-4-19(5-8-20)26-21-9-6-18-3-2-17(16-30)14-22(18)25(21)27-29(26)24(32)15-23(31)28-10-12-34-13-11-28;1-17-2-5-20(6-3-17)26-21-9-8-19-7-4-18(16-30)14-22(19)25(21)27-29(26)24(32)15-23(31)28-10-12-33-13-11-28/h3-8,15,22,26,31H,9-14,16-17H2,1-2H3;2-5,7-8,14,21,26,30H,6,9-13,15-16H2,1H3;2-7,14,21,26,30H,8-13,15-16H2,1H3/t22-,26-;2*21-,26-/m111/s1
InChIKeyLWEOBWUAGHVZKI-UBJSVJMQSA-N
XLogP7.46
TPSA233.49 Ų
H-Bond Donors3
H-Bond Acceptors16
Rotatable Bonds13
Heavy Atoms99
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001343.64
LogP ≤ 57.46
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione?
The IUPAC name of 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione (CID 159474340) is 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione.
What is the SMILES notation for 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione?
The canonical SMILES for 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione is COc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CC(=O)N2CCOCC2)cc1.Cc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CC(=O)N2CCOCC2)cc1.Cc1ccc([C@@H]2[C@@H]3CCc4ccc(CO)cc4C3=NN2C(=O)CN2CCN(C)CC2)cc1.
What is the InChIKey of 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione?
The InChIKey is LWEOBWUAGHVZKI-UBJSVJMQSA-N. The full InChI is InChI=1S/C26H32N4O2.C26H29N3O5.C26H29N3O4/c1-18-3-6-21(7-4-18)26-22-10-9-20-8-5-19(17-31)15-23(20)25(22)27-30(26)24(32)16-29-13-11-28(2)12-14-29;1-33-20-7-4-19(5-8-20)26-21-9-6-18-3-2-17(16-30)14-22(18)25(21)27-29(26)24(32)15-23(31)28-10-12-34-13-11-28;1-17-2-5-20(6-3-17)26-21-9-8-19-7-4-18(16-30)14-22(19)25(21)27-29(26)24(32)15-23(31)28-10-12-33-13-11-28/h3-8,15,22,26,31H,9-14,16-17H2,1-2H3;2-5,7-8,14,21,26,30H,6,9-13,15-16H2,1H3;2-7,14,21,26,30H,8-13,15-16H2,1H3/t22-,26-;2*21-,26-/m111/s1.
What are the key properties of 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione?
1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione has a molecular weight of 1343.64 g/mol, XLogP of 7.46, 13 rotatable bonds, 3 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methoxyphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-2-(4-methylpiperazin-1-yl)ethanone;1-[(3S,3aS)-8-(hydroxymethyl)-3-(4-methylphenyl)-3,3a,4,5-tetrahydrobenzo[g]indazol-2-yl]-3-morpholin-4-ylpropane-1,3-dione is sourced from PubChem (CID 159474340), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).